ANI Pharmaceuticals | ANIP - Operating Profit


ANI Pharmaceuticals reported $51.84M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
AbbVie USD 6.88B 156M Sep/2026
ANI Pharmaceuticals USD 51.84M 12M Sep/2026
Aurora Cannabis CAD -8.73M 1.3M Jun/2026
Canopy Growth CAD -17.58M 9.9M Jun/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Emergent BioSolutions USD -218M 69.9M Jun/2023
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novartis USD 1.84B 2.39B Sep/2026
Omeros USD -35.41M 23.75M Sep/2024
Perrigo USD 27.2M 3.7M Sep/2026
Sun Pharmaceuticals INR 39.07B 3.5B Sep/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026